OVERVIEW
OUR EQUITY STORY
UCB FINANCIALS
UCB GOVERNANCE
OUR SHAREHOLDERS
ESG OVERVIEW
DOWNLOAD CENTER
NEWS
UCB STORIES
CONTACT
SETTINGS
UCB.COM
SHARE APP
Share information
215.30
-0.55 %
31/08/2026 17:35
Open
High
Low
Volume
216.00
216.30
214.30
312,155
Latest News
31-Aug-2026
Transparency notification Wellington Management Group LLP
31-Aug-2026
UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing
30-Jul-2026
UCB Delivers Strong Results, Raises 2026 Guidance and Positions for Next Growth Phase
08-Jul-2026
UCB presents latest data from its targeted generalized myasthenia gravis treatment portfolio at International Congress on Neuromuscular Diseases 2026
Interim reports
30-Jul-2026
2026 half-year results
26-Feb-2026
2025 full-year result
31-Jul-2025
2025 half-year results
UCB Stories
30-Jul-2026
Delivering today, shaping what comes next
26-Feb-2026
Strong execution in service of patients and sustainable value
31-Jul-2025
Stronger every semester - From differentiated innovation to outstanding delivery
In Focus
30-Jul-2026 2026 Half-Year Results